ArticleCardiovascular drugs and therapy2024

Promising Drug Fondaparinux for the Treatment of COVID-19: an In Silico Analysis of Low Molecular Weight Heparin, Direct Oral Anticoagulant, and Antiplatelet Drug Interactions with Host Protease Furin.

Tugba Ertan-Bolelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.